Business Wire

CA-GUESS?

Share
GUESS and Homeboy Industries Announce the Upcycled Collection ‐ A New Way to Re‐Wear

In collaboration with Homeboy Industries, GUESS has developed a unique process to give new life to old clothing. By transforming recycled pieces into fun, fashionable creations, GUESS is building a new pathway to being fabulously sustainable. Sustainability is at the heart of all that GUESS does, and the Company’s partnership with the non‐profit Homeboy Industries represents this commitment.

GUESS will work directly with Homeboy Recycling, a social enterprise branch of Homeboy Industries on the new Upcycled Collection. In partnering with GUESS, Homeboy Recycling has expanded from exclusively electronics recycling into the world of textiles and apparel. GUESS and Homeboy Recycling have created not only a remarkable new line of goods and apparel, but a new way to support environmental sustainability, facilitate creativity, create new jobs, and uplift our community: upcycled with a whole lot of heart.

It is with absolute pride that GUESS announces the Upcycled Collection. A collection unlike any other, because no two pieces are alike. Transforming recycled clothing yields distinctly unique pieces, and that is its ultimate appeal. Tote bags, patchwork denim, bustiers, and even throw pillows; upcycled fashion for everyone. The Upcycled Collection is a sustainable, fashionable, purposeful way to shop‐the truest form of circular fashion.

“Homeboy Industries is grateful for the partnership with GUESS for the Upcycled Collection. We thank GUESS for supporting our mission to provide hope, training, and support to this marginalized population, allowing them to change the arc of their lives and become contributing members of the community. Homeboy Industries provides comprehensive trauma‐informed, wrap‐around support services such as tattoo removal, mental health services, education, legal, housing navigation, case management, workforce development, and job training,” says Chris Zwicke, CEO of Homeboy Industries. “Through this partnership, our employees at our fastest growing social enterprise, Homeboy Recycling, will gain more job skills and training, which we are very excited about.”

“The Upcycled Collection in collaboration with Homeboy Industries is designed with the hope that each piece can give purpose to a member of the community who can learn the skills needed to turn discarded merchandise into desirable, commodified items with an eye to the fashion set. The designs are determined by the resources at hand, which are carefully organized and sorted. The product range is fashion to non‐fashion pieces, so there is something for everyone. And the true joy is the wonderment around the former life of each piece and how it came to be,” says Amy Enuke, Young Contemporary Design Director.

With GUESS’ commitment to circular fashion and Homeboy Recycling’s foundation of sustainability, this partnership is the launching pad for a new kind of sustainable fashion—one that not only supports the environment but also directly supports our communities. To learn more about GUESS’ commitment to our planet, visit guess.com/sustainability

About GUESS?, Inc.

Established in 1981, GUESS began as a jeans company and has since successfully grown into a global lifestyle brand. Guess?, Inc. designs, markets, distributes and licenses a lifestyle collection of contemporary apparel, denim, handbags, watches, eyewear, footwear and other related consumer products. Guess? products are distributed through branded Guess? stores as well as better department and specialty stores around the world. As of April 30, 2022, the Company directly operated 1,073 retail stores in the Americas, Europe and Asia. The Company’s partners and distributors operated 565 additional retail stores worldwide. As of April 30, 2022, the Company and its partners and distributors operated in approximately 100 countries worldwide. For more information about the Company, please visit www.guess.com.

About Homeboy Recycling

Homeboy Recycling is a certified and award-winning social enterprise offering nationwide services for the proper disposal and management of IT assets. As one of the few R2 (Responsible Recycling) and B Corp certified companies in the world, Homeboy is committed to the highest possible standards for electronics reuse, e-waste recycling and the destruction of sensitive data. Each year, Homeboy refurbishes thousands of computers and diverts millions of pounds of electronics away from the landfill while creating jobs for people facing systemic barriers to employment. Beyond our IT asset disposition and e-waste services, we see ourselves broadly as a partner in the circular economy. We work with committed manufacturers and brands to develop socially and environmentally beneficial solutions for their products after their first life. In this capacity, we are expanding our services to include apparel/textiles and other products/materials that fit our mission.

As part of Homeboy Industries, the world’s preeminent gang rehabilitation and re-entry program, Homeboy Recycling proudly employs people committed to transforming their lives after incarceration. For more information, visit https://homeboyrecycling.com/ .

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release

Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi

Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse

Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release

Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye